Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.48 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.48 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 3/20 | 0.37 |
| ▸ | PPARA | Q07869 | 3/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.36 |
| ▸ | PNLIP | P16233 | 1/20 | 0.35 |
| ▸ | PPARD | Q03181 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4940707 | 1.00 | HCAR2 (0.48) | HCAR2KEAP1NFE2L2MAPTALDH1A1 | |
| SCHEMBL27851682 | 0.98 | HCAR2 (0.46) | HCAR2KEAP1NFE2L2MAPTALDH1A1 | |
| SCHEMBL4940415 | 0.98 | HCAR2 (0.46) | HCAR2KEAP1NFE2L2MAPTALDH1A1 | |
| SCHEMBL4582386 | 0.98 | HCAR2 (0.46) | HCAR2KEAP1NFE2L2MAPTALDH1A1 | |
| SCHEMBL4583488 | 0.96 | HCAR2 (0.48) | HCAR2KEAP1NFE2L2MAPTALDH1A1 | |
| SCHEMBL4939871 | 0.96 | HCAR2 (0.48) | HCAR2KEAP1NFE2L2MAPTALDH1A1 | |
| SCHEMBL17674566 | 0.91 | HCAR2 (0.52) | HCAR2KEAP1NFE2L2MAPTALDH1A1 | |
| SCHEMBL29626440 | 0.89 | HCAR2 (0.55) | HCAR2KEAP1NFE2L2MAPTALDH1A1 | |
| SCHEMBL31681514 | 0.89 | HCAR2 (0.55) | HCAR2KEAP1NFE2L2MAPTALDH1A1 | |
| SCHEMBL29626505 | 0.87 | HCAR2 (0.57) | HCAR2KEAP1NFE2L2MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080076699-A1 | Deconjugated alkadienoic acid esters as fragrances and or aroma substances | SYMRISE GMBH & CO. KG (DE) | 2008-03-27 | — | — | US | claimed |
| EP-1902632-A1 | Deconjugated alkadien acid esters as olefactory and or aroma substances | Symrise GmbH & Co. KG (DE) | 2008-03-26 | — | — | EP | claimed |
| CN-101910116-B | Method for production of (2E,6Z,8E)-N-isobutyl-2,6,8-decatrienamide (spilanthol), and foods, beverages, cosmetics and pharmaceutical preparations each comprising the compound | TAKASAGO PERFUMERY CO LTD | 2013-06-19 | — | — | CN | disclosed |
| CN-102471238-A | Process for producing spilanthol and intermediate for producing the same | TAKASAGO PERFUMERY CO LTD | 2012-05-23 | — | — | CN | disclosed |
| CN-101910116-A | Method for production of (2E,6Z,8E)-N-isobutyl-2,6,8-decatrienamide (spilanthol), and foods, beverages, cosmetics and pharmaceutical preparations each comprising the compound | TAKASAGO PERFUMERY CO LTD | 2010-12-08 | — | — | CN | disclosed |
| US-20080076699-A1 | Deconjugated alkadienoic acid esters as fragrances and or aroma substances | SYMRISE GMBH & CO. KG (DE) | 2008-03-27 | — | — | US | disclosed |
| EP-1902632-A1 | Deconjugated alkadien acid esters as olefactory and or aroma substances | Symrise GmbH & Co. KG (DE) | 2008-03-26 | — | — | EP | disclosed |
| EP-1525184-A1 | FLAVOURANT COMPOUNDS | Givaudan SA (CH) | 2005-04-27 | — | — | EP | disclosed |
| WO-2004011415-A1 | FLAVOURANT COMPOUNDS | GIVAUDAN SA (CH) | 2004-02-05 | — | — | WO | disclosed |
| CN-1025619-C | Process for preparing antihypercholesterolemic pyran compounds | BRISTOL MYERS CO (US) | 1994-08-10 | — | — | CN | disclosed |
| CN-1036013-A | The tetrazole compound that antihypercholesterolemic is too high and the preparation of intermediate thereof | BRISTOL MYERS CO (US) | 1989-10-04 | — | — | CN | disclosed |
| CN-88100911-A | Antihypercholesterolemic tetrazolium compounds | — | 1988-09-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080076699-A1 | Deconjugated alkadienoic acid esters as fragrances and or aroma substances | DECR1, ALOX12, ALOX15 | HCAR2 108/4885KEAP1 477/4885NFE2L2 254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.